Lincoln Pharmaceuticals Ltd (NSE:LINCOLN) Share Price

Company Profile

Business description
Lincoln Pharmaceuticals Ltd is an India-based company engaged in the business of manufacturing and trading of pharmaceutical products. It offers products in the fields of cardiac, diabetic, anti-malarial, anti-biotic, anti-fungal, cephalosporin, analgesics, anesthetics, anti-pyretic, GIT products, vitamin-minerals, and iron preparations. Some of the key brands through which the company markets its products are; Rhino, Binafin, Kezolin, Hepalin, Progut, and Vomistat among others. Geographically, it carries out sales in India and outside India; generating key revenue from outside India.
Contact
Science City Road
Lincoln House
Behind Satyam Complex
Sola
AhmedabadGJ380060
IND
T: +91 7941078000
https://www.lincolnpharma.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
1,919

Recommended

Does recent share price weakness spell opportunity in these three high-quality companies? Our analysts think so.

Joseph Taylor | 11 September 2025

The media group has excelled in controlling what it can control. Now the focus shifts to capital deployment.

Brian Han | 11 September 2025

Shares jumped in response to the latest results.

Luke Yang, CFA | 11 September 2025

Index	Last price	Change	% Change
All Ordinaries	9,128.70	18.10	0.20%
CAC 40	7,816.63	6.89	-0.09%
DAX 40	23,674.81	28.84	-0.12%
Dow JONES (US)	46,108.00	617.08	1.36%
FTSE 100	9,326.04	28.46	0.31%
HKSE	26,388.16	301.84	1.16%
NASDAQ	22,043.07	157.01	0.72%
Nikkei 225	44,768.12	395.62	0.89%
NZX 50 Index	13,227.90	1.25	-0.01%
S&P 500	6,587.47	0.00	0.00%
S&P/ASX 200	8,864.90	22.00	0.25%
SSE Composite Index	3,870.60	4.71	-0.12%